The global AI in healthcare market was valued at approximately USD 19.27 billion in 2023 and is projected to expand at a robust compound annual growth rate (CAGR) of 38.5% from 2024 to 2030. A key factor fueling this growth is the increasing demand within the healthcare sector for improved operational efficiency, enhanced diagnostic accuracy, and better patient outcomes. According to a March 2024 study conducted by Microsoft and IDC, 79% of healthcare organizations are already integrating AI technologies into their operations. Additionally, these organizations are experiencing significant returns on investment (ROI), with an estimated return of USD 3.20 for every USD 1 spent on AI, with the payback period averaging just 14 months.
AI has the potential to revolutionize several areas of healthcare, including medical imaging analysis, predictive analytics, personalized treatment planning, and drug discovery. These technologies are enabling the industry to move beyond traditional practices, offering more precise and tailored healthcare solutions.
Gather more insights about the market drivers, restrains and growth of the AI In Healthcare Market
The rapid increase in healthcare data, which is derived from various sources such as electronic health records (EHRs), medical imaging, wearable devices, and genomic sequencing, is presenting new opportunities for AI-powered solutions to extract meaningful insights that can enhance clinical decision-making. Furthermore, the growing shortage of healthcare professionals is accelerating the adoption of AI and machine learning (ML) technologies. According to the World Economic Forum's projections from May 2023, there will be a global deficit of 10 million healthcare workers by 2030, making AI-driven solutions increasingly essential. AI algorithms are being trained to analyze vast amounts of patient data, enabling healthcare providers to make faster, more accurate diagnoses and more effective treatment plans.
Government initiatives, the effects of the COVID-19 pandemic, and a surge in technological collaborations and mergers & acquisitions (M&A) have all played significant roles in driving the adoption of AI in healthcare, contributing to the rapid growth and transformation of the market.
Regional Insights
North America
In 2023, North America accounted for the largest revenue share in the AI in healthcare market, exceeding 45%. This dominance is driven by several key factors: the continuous advancement of healthcare IT infrastructure, rising healthcare spending, and the widespread adoption of artificial intelligence (AI) and machine learning (ML) technologies. In addition, supportive government initiatives, abundant funding opportunities, and the presence of major healthcare technology companies have strengthened the market. Additionally, demographic shifts such as a growing elderly population, changing lifestyles, and a rising incidence of chronic diseases have further propelled the demand for AI-based solutions. The increasing focus on value-based care, alongside heightened awareness of the potential benefits of AI, is driving continued market growth in the region.
U.S. AI in Healthcare Market Trends
The U.S. AI in healthcare market held the largest market share within North America in 2023. The demand for more efficient, personalized healthcare solutions, combined with rapid advancements in AI research—particularly in machine learning (ML) and natural language processing (NLP)—has significantly contributed to market growth. Furthermore, regulatory support and the development of favorable policies have accelerated AI adoption. The U.S. market's emphasis on personalized medicine, faster diagnostics, and improving patient outcomes has reinforced the role of AI in transforming healthcare delivery.
Europe AI in Healthcare Market Trends
The AI in healthcare market in Europe is expected to experience robust growth in the coming years. The growth can be attributed to the increasing adoption of AI technologies and substantial investments from both governmental and private entities. For instance, in 2021, the UK’s Department of Health and Social Care allocated £36 million (USD 49.3 million) to support 38 AI initiatives focused on improving patient care and expediting diagnoses. Europe is also experiencing significant uptake of AI technologies in key healthcare areas like medical imaging, predictive analytics, and personalized treatment plans, further driving market expansion.
The UK held the largest share of the AI healthcare market in Europe in 2023. AI applications, particularly in medical imaging analysis, predictive analytics, and personalized treatment planning, have become increasingly integral to healthcare delivery. The National Health Service (NHS) in the UK is particularly active in exploring AI technologies to optimize operations, enhance patient care, and address various challenges in the healthcare system.
Asia Pacific AI in Healthcare Market Trends
The AI in healthcare market in Asia Pacific is poised for significant growth in the near future, driven by rapid technological innovations and advancements in IT infrastructure. This region is also seeing a rise in entrepreneurial ventures focused on AI-driven healthcare solutions. Increased investments from private investors, venture capitalists, and non-profit organizations are pushing the adoption of AI technologies to improve clinical outcomes, enhance data analysis and security, and reduce healthcare costs. Additionally, government initiatives supporting AI adoption among healthcare providers are expected to further accelerate market growth across the region.
China dominated the AI in healthcare market in Asia Pacific in 2023. The adoption of AI technologies, particularly in diagnostic imaging, medical diagnostics, and robot-assisted surgeries, has been increasing significantly. Notable partnerships, such as the one between Partners Healthcare and FUJIFILM Sonosite in 2019, aimed to develop AI-based ultrasound technology, exemplify the country’s focus on improving healthcare accessibility and diagnostic capabilities.
Latin America AI in Healthcare Market Trends
The AI in healthcare market in Latin America is projected to grow substantially in the coming years. This growth is primarily fueled by rising awareness of AI technologies, increased government investments in healthcare innovation, and a growing trend of collaboration between public and private sectors. The focus on improving healthcare infrastructure and access, particularly in underserved areas, is also driving the adoption of AI solutions to enhance the efficiency and effectiveness of healthcare delivery.
Middle East & Africa AI in Healthcare Market Trends
The AI in healthcare market in the Middle East and Africa is expected to experience strong growth over the forecast period. The increasing prevalence of chronic diseases in the region, coupled with the growing demand for accurate and efficient diagnostic and treatment methods, is prompting healthcare providers to integrate AI into their systems. Governments and healthcare organizations in the region are increasingly recognizing the potential of AI technologies to address these healthcare challenges and improve the quality of care provided to patients. As a result, AI adoption in the region is expected to accelerate in the coming years.
Browse through Grand View Research's Category Healthcare IT Industry Research Reports.
- The global AI in oncology market size was estimated at USD 2.80 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 28.92% from 2024 to 2030.
- The global population health management market size was estimated at USD 70.0 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 22.0% from 2024 to 2030.
Key AI in Healthcare Company Insights
Companies operating in the AI healthcare sector are actively employing a range of innovative strategies to enhance their market presence. This includes the development of new products that meet the evolving needs of healthcare providers and patients. Additionally, these market players are forming strategic partnerships and pursuing mergers and acquisitions to bolster their capabilities and resources. This proactive approach is largely driven by a growing demand for early and precise disease detection, effective cost containment, and solutions to the ongoing shortage of healthcare professionals. Furthermore, there is a strong emphasis on delivering value-based care, which aligns healthcare services more closely with patient outcomes.
AI Startup Ecosystem
The AI healthcare landscape is vibrant and dynamic, characterized by a multitude of startups that are energized by substantial funding, significant investments, and innovative ideas. These emerging companies are harnessing the power of artificial intelligence and machine learning to tackle a variety of pressing healthcare challenges. Their applications range widely, including advancements in medical imaging and diagnostics, breakthroughs in drug discovery, and enhancements in telemedicine services. This startup ecosystem plays a crucial role in driving innovation and improving healthcare delivery across the industry.
Key AI In Healthcare Companies:
The following are the leading companies in the AI in healthcare market. These companies collectively hold the largest market share and dictate industry trends.
- Microsoft
- IBM
- NVIDIA Corporation
- Intel Corporation
- Itrex Group
- GE Healthcare
- Medtronic
- Oracle
- Medidata
- Merck
- IQVIA
Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian